Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic disease.
about
Ultra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the block.Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.Impact of five-tiered Gleason grade groups on prognostic prediction in clinical stage T3 prostate cancer undergoing high-dose-rate brachytherapy.
P2860
Whole body MRI (WB-MRI) assessment of metastatic spread in prostate cancer: Therapeutic perspectives on targeted management of oligometastatic disease.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Whole body MRI (WB-MRI) assess ...... nt of oligometastatic disease.
@en
Whole body MRI
@nl
type
label
Whole body MRI (WB-MRI) assess ...... nt of oligometastatic disease.
@en
Whole body MRI
@nl
prefLabel
Whole body MRI (WB-MRI) assess ...... nt of oligometastatic disease.
@en
Whole body MRI
@nl
P2093
P2860
P356
P1433
P1476
Whole body MRI (WB-MRI) assess ...... nt of oligometastatic disease.
@en
P2093
Ahmed Larbi
Anwar Padhani
Benjamin Dallaudière
Bertrand Tombal
Bruno C Vande Berg
Frédéric E Lecouvet
Nicolas Michoux
Vasiliki Pasoglou
P2860
P304
P356
10.1002/PROS.23196
P577
2016-05-16T00:00:00Z